OUR PRODUCTS

MOBILE APPS

GENERAL INFO

OMER

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Omeros (OMER) Earnings Date & Reports

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

OMER is expected to report earnings to rise 4.07% to -44 cents per share on November 05

Q3'25

Est.

$-0.45

Q2'25

Beat

by $0.03

Q4'24

Beat

by $0.15

Q3'24

Beat

by $0.13

Q2'24

Missed

by $0.27

The last earnings report on August 14 showed earnings per share of -43 cents, beating the estimate of -46 cents. With 630.28K shares outstanding, the current market capitalization sits at 285.83M.

View a ticker or compare two or three

Compare

OMER

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For OMER
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OMER showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

201 Elliott Avenue West

Phone

+1 206 676-5000

Employees

198

Web

https://www.omeros.com